ATE232536T1 - N-(2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4- - Google Patents
N-(2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-Info
- Publication number
- ATE232536T1 ATE232536T1 AT98958672T AT98958672T ATE232536T1 AT E232536 T1 ATE232536 T1 AT E232536T1 AT 98958672 T AT98958672 T AT 98958672T AT 98958672 T AT98958672 T AT 98958672T AT E232536 T1 ATE232536 T1 AT E232536T1
- Authority
- AT
- Austria
- Prior art keywords
- compound
- benzyloxycarbonyl
- oxo
- amino
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7191898P | 1998-01-20 | 1998-01-20 | |
PCT/US1998/024848 WO1999036426A1 (en) | 1998-01-20 | 1998-11-20 | N-[2-(5-BENZYLOXYCARBONYL-AMINO-6-OXO-2-(4-FLUOROPHENYL)-1,6-DIHYDRO-1-PYRIMIDINYL)ACETO- XYL]-L-ASPARTIC ACID ALDEHYDE AS AN IN VIVO INHIBITOR OF INTERLEUKIN-1β CONVERTING ENZYME (ICE) |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE232536T1 true ATE232536T1 (de) | 2003-02-15 |
Family
ID=22104428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98958672T ATE232536T1 (de) | 1998-01-20 | 1998-11-20 | N-(2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4- |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1049703B1 (de) |
JP (1) | JP2002509153A (de) |
AT (1) | ATE232536T1 (de) |
AU (1) | AU1466399A (de) |
CA (1) | CA2309546A1 (de) |
DE (1) | DE69811404T2 (de) |
DK (1) | DK1049703T3 (de) |
ES (1) | ES2193589T3 (de) |
PT (1) | PT1049703E (de) |
WO (1) | WO1999036426A1 (de) |
ZA (1) | ZA99369B (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6664255B1 (en) | 1999-05-19 | 2003-12-16 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
US6716838B1 (en) | 1999-05-19 | 2004-04-06 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
US6653316B1 (en) | 1999-05-19 | 2003-11-25 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
US6750342B1 (en) | 1999-05-19 | 2004-06-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
US6867217B1 (en) | 1999-05-19 | 2005-03-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
US6458952B1 (en) | 1999-05-19 | 2002-10-01 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
US7015230B1 (en) | 1999-05-19 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
AU2001243598A1 (en) | 2000-03-13 | 2001-09-24 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
EP1268428A2 (de) | 2000-04-05 | 2003-01-02 | Pharmacia Corporation | Polyzyklische aryl und heteroaryl substituierte 4-pyridon-derivate verwendbar zur selektiven hemmung der blutgerinnungskaskade |
PT1268463E (pt) | 2000-04-05 | 2005-05-31 | Pharmacia Corp | 4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao |
WO2001079155A2 (en) | 2000-04-17 | 2001-10-25 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
WO2001087851A1 (en) * | 2000-05-18 | 2001-11-22 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
PE20011350A1 (es) | 2000-05-19 | 2002-01-15 | Vertex Pharma | PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE) |
WO2002006242A2 (en) * | 2000-07-18 | 2002-01-24 | Neurogen Corporation | 5-substituted 2-aryl-4-pyrimidinones |
US7015223B1 (en) | 2000-11-20 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
CA2430037A1 (en) | 2000-11-20 | 2002-05-30 | Michael S. South | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
US7119094B1 (en) | 2000-11-20 | 2006-10-10 | Warner-Lambert Company | Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade |
MXPA04000134A (es) | 2001-06-26 | 2005-06-06 | Abgenix Inc | Anticuerpos para ligandos de osteoprotegerina. |
US6969715B2 (en) | 2001-10-03 | 2005-11-29 | Pharmacia Corporation | 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
MXPA04003170A (es) | 2001-10-03 | 2004-07-08 | Pharmacia Corp | Compuestos policiclicos, sustituidos, provisto de 5 miembros, utiles para la inhibicion selectiva de la cascada de coagulacion. |
BRPI0314038B8 (pt) | 2002-09-06 | 2021-05-25 | Amgen Inc | anticorpo humano isolado, molécula de ácido nucleico isolada, vetor, uso de um anticorpo, e, composição farmacêutica |
EP2399916B1 (de) | 2004-03-12 | 2014-12-10 | Vertex Pharmaceuticals Incorporated | Verfahren und Zwischenprodukte zur Herstellung von Asparaginacetal-Caspase-Inhibitoren |
AU2005247409B2 (en) | 2004-05-15 | 2011-11-10 | Vertex Pharmaceuticals Incorporated | Treating seizures using ICE inhibitors |
EP1778221A2 (de) | 2004-05-27 | 2007-05-02 | Vertex Pharmaceuticals Incorporated | Ice-hemmer zur behandlung von autoinflammatorischen erkrankungen |
JP2009502922A (ja) | 2005-07-28 | 2009-01-29 | バーテックス ファーマシューティカルズ インコーポレイテッド | カスパーゼ阻害剤プロドラッグ |
EP2635906A4 (de) | 2010-11-05 | 2014-04-02 | Univ Brandeis | Ice-hemmende verbindungen und ihre verwendungen |
EP3836954A1 (de) | 2018-08-13 | 2021-06-23 | Iltoo Pharma | Kombination von interleukin-2 mit einem interleukin-1-inhibitor, konjugate und therapeutische verwendungen davon |
WO2023222565A1 (en) | 2022-05-16 | 2023-11-23 | Institut National de la Santé et de la Recherche Médicale | Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5441960A (en) * | 1992-04-16 | 1995-08-15 | Zeneca Limited | 1-pyrimidinylacetamide human leukocyte elastate inhibitors |
CA2186511C (en) * | 1994-03-31 | 2009-02-10 | Roland E. Dolle | Pyrimidinyl derivatives as interleukin inhibitors |
-
1998
- 1998-11-20 CA CA002309546A patent/CA2309546A1/en not_active Abandoned
- 1998-11-20 AU AU14663/99A patent/AU1466399A/en not_active Abandoned
- 1998-11-20 AT AT98958672T patent/ATE232536T1/de not_active IP Right Cessation
- 1998-11-20 JP JP2000540142A patent/JP2002509153A/ja not_active Abandoned
- 1998-11-20 ES ES98958672T patent/ES2193589T3/es not_active Expired - Lifetime
- 1998-11-20 DK DK98958672T patent/DK1049703T3/da active
- 1998-11-20 WO PCT/US1998/024848 patent/WO1999036426A1/en active IP Right Grant
- 1998-11-20 DE DE69811404T patent/DE69811404T2/de not_active Expired - Fee Related
- 1998-11-20 PT PT98958672T patent/PT1049703E/pt unknown
- 1998-11-20 EP EP98958672A patent/EP1049703B1/de not_active Expired - Lifetime
-
1999
- 1999-01-19 ZA ZA9900369A patent/ZA99369B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2309546A1 (en) | 1999-07-22 |
DK1049703T3 (da) | 2003-06-02 |
EP1049703A1 (de) | 2000-11-08 |
AU1466399A (en) | 1999-08-02 |
DE69811404T2 (de) | 2003-12-04 |
JP2002509153A (ja) | 2002-03-26 |
ES2193589T3 (es) | 2003-11-01 |
DE69811404D1 (de) | 2003-03-20 |
PT1049703E (pt) | 2003-06-30 |
WO1999036426A1 (en) | 1999-07-22 |
EP1049703B1 (de) | 2003-02-12 |
ZA99369B (en) | 1999-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE232536T1 (de) | N-(2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4- | |
NO991674L (no) | Interleukin-1<Beta>omdannelsesenzym-inhibitor-sulfonamider | |
LU91145I2 (fr) | FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX). | |
ATE171165T1 (de) | 2- (dihydro)pyrazolyl-3'-oxymethylen>-anilide als schädlingsbekämpfungsmittel und fungizide | |
CA2338220A1 (en) | Substituted imidazoles having cytokine inhibitory activity | |
PT100300B (pt) | Derivados de aminas heterociclicas-ciclicas, nomeadamente derivados de benzisoxazole-piperidina | |
EA199800923A1 (ru) | Новые 2,3-двузамещенные 4(3н)-хиназолины | |
DE69615682D1 (de) | N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide | |
ES2163506T3 (es) | Derivados de bencimidazolona con actividad dopaminergica central. | |
AP2000001992A0 (en) | Succinamide inhibitors of inteleukin-1B converting enzyme. | |
DE69811360D1 (de) | Diazepinoindolone als phophodiesterase 4 inhibitoren | |
EA200000741A1 (ru) | Новые производные дигидроксигексановой кислоты | |
EA200000204A1 (ru) | Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов | |
CO4410330A1 (es) | Nuevos derivados de bencimidazol farmacologicamente activos y sus sales de adicion acida | |
IL129124A0 (en) | Sulfonamide substituted aspartic acid interleukin -1beta converting enzyme inhibitors | |
DE60133385D1 (de) | (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol oder prodrug davon zur behandlung von demenzsymptomen oder kognitiven störungen | |
BR9916189A (pt) | Derivados de amida arilpiperidina e aril-1,2,5,6-tetraidropiridina tendo atividade receptora 5ht1a | |
ATE190617T1 (de) | Substituierte 4-(6-fluor-(1h)-indol-3-yl)1,2,3,6- tetrahydropyridin-derivate für die behandlung von zns-störungen | |
FR2772753B1 (fr) | Procede de synthese d'acetals | |
IT1279362B1 (it) | Caldaia particolarmente per l'utilizzazione di scarti di lavorazione |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1049703 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |